Coronary Artery Disease and Atherosclerosis Flashcards
Describe the expected burden of IHD
By 2020, will be the highest global killer. Increasing because of the epidemiological shift- developing countries have more westernised lifestyles.
What is atherosclerosis
A progressive, inflammatory disease of large and medium sized arteries.
Describe the areas of medicine that atherosclerosis involves
Neurology (cerebrovascular disease) Cardiology (coronary disease) Cardiac Surgery (revascularization) Vascular Surgery (revascularization) Endocrinology (diabetes) Metabolic medicine (lipids) Acute Medicine (Heart attack Stroke)
What are the modifiable risk factors for atherosclerosis
Smoking
Lipid intake- can be controlled by pharmacological means and diet
Blood pressure- diet control (low salt) and medications
Diabetes- low sugar, lose weight, pharmacological (metformin, sulphonylurea)
Obesity- diet, exercise, drugs (lipid absorption, appetite, gastric bands)
Sedentary Lifestyle - exercise
What are the non-modifiable risk factors for atherosclerosis
Age- increased age increases number and severity of lesions
Sex- men are affected to a much greater extent than women, until the menopause when the incidence in women increases- cardioprotective effects of oestrogen.
Genetic background- at least 50% of risk.
What are we concerned with in the clinic
Modifiable risk factors.
Explain the interaction of the risk factors
Have a multiplicative effect
Describe the changes in the epidemiology over the past decade
Reduced hyperlipidaemia (statin treatment
Reduced hypertension (antihypertensive treatment
New improvements in diabetes treatment have doubtful effect on macrovascular disease
Increased obesity Increased diabetes
Changing pathology of coronary thrombosis possibly related to altered risk factors
What are the clinical trials for SGLT2 inhibitors indicating
Diabetes drugs- still ongoing- little effect on microvascular disease.
Where do atherosclerotic plaques tend to form
Bifurcations
Due to haemodynamic
Create eddys in blood- more turbulent flow in these areas.
Describe the deposition of LDL
Low density lipoproteins (LDL) deposit in the subintimal space and binds to matrix proteoglycans.
Describe the progression of atherosclerosis
lesion prone location- adaptive smooth muscle thickening following LDL deposition
Type 2 lesion- becomes inflammatory- population of foam cells (fat filled macrophages)
Type 3 -preatheroma- foam cells release fat as they die- small pools of extracellular lipid on artery wall
Type 4 (atheroma)- small pools of lipid coalesce to form necrotic core of extracellular lipid.
Type 5 (fibroatheroma)- fibrous thickening (collagen) lies over core, beneath the endothelium
Type 6 (complicated lesion)- if fibrous thickening not enough and cap cracks apart, triggering thrombus that can occlude artery
Describe the appearance of the type 6 lesion
Stratified appearance
As development is stepwise
Grows incrementally in small steps as you age.
What does the stability of the plaque depend on
The stability of the plaque is dependent on the strength and thickness of the fibrous cap, which relies on the balance between inflammation and repair. If this balance is disturbed and inflammation predominates, the cap may become thinner, less stable and may rupture.
Counterintuitively, we want a thick, fibrous cap as it prevents MI.
Where does the window of opportunity for lifestyle interventions lie
Intermediate and advanced lesions
lifestyle changes and risk factor management during intermediate/advanced lesion stage
Describe the clinical interventions for complicated plaques
Secondary prevention
Catheter based interventions
Revascularisation surgery
Treatment of heart failure
Describe percutaneous coronary intervention
Number of procedures to relieve stenosis in the coronary arteries.
Performed by the insertion of a catheter- usually via the femoral artery.
Balloon angioplasty: compresses the plaque; expands the lumen
Metal stent- positioned within the stenosis- expanding vessel walls and restoring vessel patency- should be coated with immuno-suppressive agents- to reduce the risk of re-stenosis.
Describe coronary artery bypass graft
The procedure uses autologous veins and/or arteries to bypass stenosis in coronary arteries.
Describe the role of vascular endothelial cells
surface for leukocyte recruitment Barrier function (e.g. to lipoproteins)
Describe the roles of platelets
Thrombus generation
Cytokine and growth factor release - causing smooth muscle cell migration from the media to the intima